Jonathan E. Schelfhout
Impact in
-
- Respiratory and Cough-Related Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Physiology top 5%
- Adenosine and Purinergic Signaling
- Asthma and respiratory diseases
Papers in
-
- Respiratory and Cough-Related Research 43
-
- Cytomegalovirus and herpesvirus research 5
- Co-authors
- Allison Martin Nguyen (11 shared papers)David R. Muccino (10 shared papers)Surinder Singh Birring (10 shared papers)Carmen La Rosa (10 shared papers)Lorcan P. McGarvey (9 shared papers)Peter V. Dicpinigaitis (9 shared papers)Alyn Hugh Morice (8 shared papers)John A. Smith (9 shared papers)
- Journals
- Lung (5 papers)BMC Pulmonary Medicine (4 papers)Therapeutic Advances in Respiratory Disease (4 papers)ERJ Open Research (4 papers)Journal of Allergy and Clinical Immunology (4 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Jonathan E. Schelfhout
49 papers receiving 992 citations
Jonathan E. Schelfhout's Hit Papers
Peers
Comparison fields: 5 of 64
- Pulmonary and Respiratory Medicine 798
- Physiology 44
- Health Informatics 6
- Physiology 50
- Sensory Systems 9
Countries citing papers authored by Jonathan E. Schelfhout
This map shows the geographic impact of Jonathan E. Schelfhout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan E. Schelfhout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan E. Schelfhout more than expected).
Fields of papers citing papers by Jonathan E. Schelfhout
This network shows the impact of papers produced by Jonathan E. Schelfhout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan E. Schelfhout. The network helps show where Jonathan E. Schelfhout may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan E. Schelfhout, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials Hit paper breakdown → | 2022 | 239 |
| 2 | 2021 | 85 | |
| 3 | 2021 | 76 | |
| 4 | 2022 | 49 | |
| 5 | 2021 | 47 | |
| 6 | 2021 | 36 | |
| 7 | 2020 | 31 | |
| 8 | 2020 | 30 | |
| 9 | 2023 | 29 | |
| 10 | 2023 | 27 | |
| 11 | 2022 | 25 | |
| 12 | 2020 | 24 | |
| 13 | 2019 | 23 | |
| 14 | 2021 | 22 | |
| 15 | 2022 | 21 | |
| 16 | 2020 | 17 | |
| 17 | 2022 | 17 | |
| 18 | 2021 | 16 | |
| 19 | 2022 | 16 | |
| 20 | 2023 | 13 |
About Jonathan E. Schelfhout
Jonathan E. Schelfhout is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Health Information Management, Public Health, Environmental and Occupational Health and Geriatrics and Gerontology, having authored 51 papers that have together received 1k indexed citations. Recurring topics across this work include Respiratory and Cough-Related Research (43 papers), Cytomegalovirus and herpesvirus research (5 papers), Opioid Use Disorder Treatment (3 papers), Medical Coding and Health Information (2 papers), Machine Learning in Healthcare (2 papers), Hepatitis C virus research (1 paper), Artificial Intelligence in Healthcare (1 paper) and Pharmaceutical Practices and Patient Outcomes (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (798 citations), Physiology (44 citations), Health Informatics (6 citations), Physiology (50 citations) and Sensory Systems (9 citations). Jonathan E. Schelfhout has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Allison Martin Nguyen, David R. Muccino, Surinder Singh Birring, Carmen La Rosa, Lorcan P. McGarvey, Peter V. Dicpinigaitis, Alyn Hugh Morice, John A. Smith, Elizabeth Dansie Bacci and Margaret Vernon. Their work appears in journals such as Lung, BMC Pulmonary Medicine, Therapeutic Advances in Respiratory Disease, ERJ Open Research and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.